| ALKERMES PLC DL-,01 |
| Irland |
| Gesundheit |
| IE00B56GVS15 / A1JKVH |
| 8AK (Frankfurt) / ALKS (NASDAQ) |
| FRA:8AK, ETR:8AK, 8AK:GR, NASDAQ:ALKS |
| - |
| https://www.alkermes.com/ |
|
Alkermes plc is an Ireland-based, fully integrated global biopharmaceutical company focused on developing and commercializing innovative medicines in neuroscience. It specializes in treatments for serious mental illnesses, addiction, schizophrenia, b..
>Volltext.. |
| 4256.24 Mio. EUR |
| 3190.43 Mio. EUR |
| 1282.56 Mio. EUR |
| 244.29 Mio. EUR |
| 210.01 Mio. EUR |
| 1.27 EUR |
| 60.83 Mio. EUR |
| 973.09 Mio. EUR |
| 452.54 Mio. EUR |
| 2.43 |
| -16.48% |
| -41.97% |
| - |
| - |
| - |
| ALKERMES |
| 31.03.26 |
|